药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
4-Bromo-2,5-dimethoxyamphetamine
AICA ribonucleotide
The therapeutic efficacy of AICA ribonucleotide can be increased when used in combination with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Picosulfuric acid
The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
(S)-Warfarin
The metabolism of (S)-Warfarin can be increased when combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
S,R-Warfarin alcohol
The metabolism of S,R-Warfarin alcohol can be increased when combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
R,S-Warfarin alcohol
The metabolism of R,S-Warfarin alcohol can be increased when combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
(R)-warfarin
The metabolism of (R)-warfarin can be increased when combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Perampanel
The metabolism of Perampanel can be increased when combined with Delafloxacin.
4-Bromo-2,5-dimethoxyamphetamine
Ferric oxyhydroxide
Ferric oxyhydroxide can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Calcium polycarbophil
Calcium polycarbophil can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Lanthanum III cation
Lanthanum III cation can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Tetraferric tricitrate decahydrate
Tetraferric tricitrate decahydrate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Ferric pyrophosphate citrate
Ferric pyrophosphate citrate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Ferric cation
Ferric cation can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Ferric sulfate
Ferric sulfate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Calcium gluconate
Calcium gluconate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Sodium ferric gluconate complex
Sodium ferric gluconate complex can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Ferric pyrophosphate
Ferric pyrophosphate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Iron sucrose
Iron sucrose can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Ferric carboxymaltose
Ferric carboxymaltose can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
4-Bromo-2,5-dimethoxyamphetamine
Lanthanum carbonate
Lanthanum carbonate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.